Well, I think biotech and drug manufacturers are going to go a route similar to anti-virus software... or any other software for that matter. A "drug platform" will run "bio-software" to create and administer just the right drugs in the correct dosages for your body... Everyone will have their own "Auto-Pharm." And since manufacturing, distribution, and even marketing will not be a big issue in the case of rare disorders, drug companies will be compete more on the comprehensiveness of their library of cures and treatments.
Slashdot Mirror
a leak is not always illegal; But the leaker may be breaking contractual obligations
Well, I think biotech and drug manufacturers are going to go a route similar to anti-virus software... or any other software for that matter. A "drug platform" will run "bio-software" to create and administer just the right drugs in the correct dosages for your body... Everyone will have their own "Auto-Pharm." And since manufacturing, distribution, and even marketing will not be a big issue in the case of rare disorders, drug companies will be compete more on the comprehensiveness of their library of cures and treatments.